{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:55:31Z","timestamp":1793163331726,"version":"4.5.0"},"reference-count":50,"publisher":"Informa UK Limited","issue":"12","license":[{"start":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T00:00:00Z","timestamp":1607644800000},"content-version":"unspecified","delay-in-days":51,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017239","name":"BeiGene","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017239","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2020,12,1]]},"DOI":"10.1080\/13543784.2020.1833857","type":"journal-article","created":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T15:56:53Z","timestamp":1602518213000},"page":"1355-1364","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":63,"title":["Tislelizumab: an investigational anti-PD-1 antibody for the treatment of advanced non-small cell lung cancer (NSCLC)"],"prefix":"10.1080","volume":"29","author":[{"given":"Si-Yang","family":"Liu","sequence":"first","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, School of Medicine, Guangdong Lung Cancer Institute, Guangdong Provincial People\u2019s Hospital and Guangdong Academy of Medical Sciences, South China University of Technology, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Long","family":"Wu","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, School of Medicine, Guangdong Lung Cancer Institute, Guangdong Provincial People\u2019s Hospital and Guangdong Academy of Medical Sciences, South China University of Technology, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,10,21]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq189"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.170070"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00137"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-019-0779-5"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.106"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.13-S4-16"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1007\/s00508-017-1285-9"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01281-7"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.71.9476"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2018.05.004"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504627"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1507643"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1809697"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.66.9929"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1111\/ajco.12608"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1809064"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1810865"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801005"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00149"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32409-7"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz295"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1613493"},{"issue":"5","key":"cit0024","first-page":"v851","volume":"30","author":"Spigel D","year":"2019","journal-title":"Ann Oncol"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.0237"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.9501"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.03136"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716948"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30167-6"},{"issue":"20","key":"cit0030","first-page":"30292","volume":"1556","author":"Jotte R","year":"2020","journal-title":"J Thorac Oncol"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-018-2160-x"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2015.08.004"},{"key":"cit0033","first-page":"Abstract 4048","volume-title":"Proceedings of the 110th Annual Meeting of the American Association for Cancer Research","author":"Feng Y","year":"2019"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2018.1556465"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-2607"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200690"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-020-01286-z"},{"issue":"1","key":"cit0038","first-page":"AbstractP154","volume":"4","author":"Desai J","year":"2016","journal-title":"J Immunother Cancer"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz244.045"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000453"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2019.08.1538"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000437"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2020.06.007"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.08.1578"},{"key":"cit0045","unstructured":"BeiGene announces that the phase 3 trial of tislelizumab combined with chemotherapy in patients with first-line non-squamous non-small cell lung cancer met the primary endpoint of progression-free survival at interim analysis. [cited 2020 Jul 09]. Available from: http:\/\/ir.beigene.com\/news-releases\/news-release-details\/beigene-announces-phase-3-trial-tislelizumab-combined"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801946"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20174251"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01161"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0134-3"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-018-0058-3"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543784.2020.1833857","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T05:38:00Z","timestamp":1620452280000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543784.2020.1833857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,21]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12,1]]}},"alternative-id":["10.1080\/13543784.2020.1833857"],"URL":"https:\/\/doi.org\/10.1080\/13543784.2020.1833857","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,21]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-08-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}